Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
OBJECTIVES: To evaluate the association between improvements in physical function, fatigue and pain and improvements in productivity at work and at home in patients treated with certolizumab pegol (CZP) in combination with MTX. METHODS: Physical function, fatigue and pain were assessed in two CZP c...
Main Authors: | Hazes, J, Taylor, P, Strand, V, Purcaru, O, Coteur, G, Mease, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2010
|
פריטים דומים
-
Certolizumab pegol in therapy for rheumatoid arthritis
מאת: Galina Viktorovna Lukina, et al.
יצא לאור: (2012-06-01) -
COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
מאת: Purcaru, O, et al.
יצא לאור: (2010) -
QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
מאת: Vera Nikolayevna Amirdjanova, et al.
יצא לאור: (2012-10-01) -
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
מאת: M Connock, et al.
יצא לאור: (2010-10-01) -
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
מאת: Ruiz Garcia, V, et al.
יצא לאור: (2014)